NCT05624983View on ClinicalTrials.gov

Exploration of High Frequency Otoacoustic Emissions and Developmental Language Disorders

NANot yet recruitingINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

July 1, 2027

Study Completion Date

July 1, 2027

Conditions
Language Development Disorders
Interventions
DIAGNOSTIC_TEST

acoustic otoemisions

TOAE and DPOAE

DIAGNOSTIC_TEST

Otoscopy

presence of earwax checked by video otoscop

DIAGNOSTIC_TEST

Audiometry

Hearing Threshold will be measured with the AD528 interacoustics

DIAGNOSTIC_TEST

Tympanometry

Tympanic mobility will be measyred with the Titan interacoustics

Trial Locations (1)

Unknown

CHU Clermont-Ferrand, UMR INSERM 1107, Clermont-Ferrand

All Listed Sponsors
lead

University Hospital, Clermont-Ferrand

OTHER

NCT05624983 - Exploration of High Frequency Otoacoustic Emissions and Developmental Language Disorders | Biotech Hunter | Biotech Hunter